||
免疫微环境的异质性是肿瘤耐药、复发和预后差的重要原因之一。近年来,免疫治疗及相关联合治疗方案给晚期肿瘤患者带来希望,系统探究肿瘤免疫微环境的异质性对于治疗选择、疗效预测、方案优化及开发新的免疫治疗靶点等有重要指导作用。然而,对肝癌免疫微环境的异质性仍缺乏系统深入的认知,亟需无偏差的、包含所有细胞亚型的研究策略以系统揭示肝癌免疫微环境的异质性。https://www.ebiotrade.com/newsf/2022-12/20221208065337573.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=2d5be168-fc2a-487b-9bca-4c0592d9f94e
01. | 无法确认 | 6 篇 | 3.279% |
02. | 2022 | 80 篇 | 43.716% |
03. | 2021 | 53 篇 | 28.962% |
04. | 2020 | 19 篇 | 10.383% |
05. | 2019 | 8 篇 | 4.372% |
06. | 2018 | 7 篇 | 3.825% |
07. | 2017 | 3 篇 | 1.639% |
08. | 2016 | 2 篇 | 1.093% |
01. | front immunol | 22 篇 | 12.022% |
02. | aging (albany ny) | 8 篇 | 4.372% |
03. | front oncol | 8 篇 | 4.372% |
04. | sci rep | 8 篇 | 4.372% |
05. | hepatology | 6 篇 | 3.279% |
06. | bmc cancer | 5 篇 | 2.732% |
07. | front mol biosci | 4 篇 | 2.186% |
08. | front genet | 3 篇 | 1.639% |
09. | int j mol sci | 3 篇 | 1.639% |
10. | j oncol | 3 篇 | 1.639% |
01. | 中国 | 130 篇 | 71.038% |
02. | 美国 | 21 篇 | 11.475% |
03. | 日本 | 10 篇 | 5.464% |
04. | 德国 | 7 篇 | 3.825% |
05. | 西班牙 | 5 篇 | 2.732% |
06. | 奥地利 | 4 篇 | 2.186% |
07. | 挪威 | 4 篇 | 2.186% |
08. | 英国 | 4 篇 | 2.186% |
09. | 澳大利亚 | 3 篇 | 1.639% |
10. | 巴基斯坦 | 2 篇 | 1.093% |
01. | 中国上海 | 26 篇 | 14.208% |
02. | 中国北京 | 15 篇 | 8.197% |
03. | 中国广州 | 15 篇 | 8.197% |
04. | 中国杭州 | 13 篇 | 7.104% |
05. | 中国郑州 | 13 篇 | 7.104% |
06. | 中国武汉 | 10 篇 | 5.464% |
07. | 中国成都 | 10 篇 | 5.464% |
08. | 中国南京 | 7 篇 | 3.825% |
09. | 中国温州 | 6 篇 | 3.279% |
10. | 中国长沙 | 6 篇 | 3.279% |
01. | Humans | 129 篇 | 70.492% |
02. | Tumor Microenvironment | 112 篇 | 61.202% |
03. | Liver Neoplasms | 91 篇 | 49.727% |
04. | Carcinoma, Hepatocellular | 84 篇 | 45.902% |
05. | Prognosis | 60 篇 | 32.787% |
06. | Biomarkers, Tumor | 47 篇 | 25.683% |
07. | Gene Expression Regulation, Neoplastic | 40 篇 | 21.858% |
08. | Female | 32 篇 | 17.486% |
09. | Male | 29 篇 | 15.847% |
10. | Gene Expression Profiling | 27 篇 | 14.754% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-10-20 02:57
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社